文献速递中药与中成药合理使用

归脾汤与八物汤对大鼠吉非替尼药代动力学的影响

Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in Rats.
PubMed 文献 · Chin J Integr Med · 2018-01-15

研究评估中药归脾汤(GPD)和八物汤(BWD)与抗癌药吉非替尼在大鼠体内的药代动力学相互作用。单次或多次给予BWD后,吉非替尼的Cmax和AUC显著降低,Tmax延迟;而GPD对吉非替尼药代动力学无影响。结论提示BWD可能干扰吉非替尼吸收,需进一步临床评价。

要点

  • BWD(八物汤)可能降低吉非替尼的峰浓度和暴露量并延迟达峰时间。
  • GPD(归脾汤)对吉非替尼药代动力学无显著影响。
  • 临床联用八物汤与吉非替尼时需关注潜在吸收干扰。

核心结论

  • 八物汤而非归脾汤可能延迟并干扰吉非替尼的吸收。

研究设计与样本

  • 大鼠随机分为甲基纤维素对照组、归脾汤组(1200 mg/kg)和八物汤组(6000 mg/kg),分别单次或多次(7天)预处理后口服吉非替尼10 mg/kg。

主要发现

  • 吉非替尼消除半衰期为3.7-4.1 h。
  • 归脾汤预处理不影响吉非替尼药代动力学。
  • 八物汤单次和多次预处理均使吉非替尼Cmax和AUC显著降低(P<0.05),Tmax显著延迟(P<0.01)。

关键数值与推荐

  • 八物汤组与对照组相比,Cmax和AUC的P值均小于0.05,Tmax的P值小于0.01。

临床怎么用

  • 接受吉非替尼治疗的患者应谨慎联用八物汤,并监测疗效与血药浓度。

局限性

  • 研究仅在大鼠中进行,临床意义需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the potential pharmacokinetic interactions of the anticancer agent gefitinib (Iressa®) and the oriental medications Guipi Decoction (, GPD, Guibi-tang in Korean) and Bawu Decoction (, BWD, Palmul-tang in Korean). METHODS: Methylcellulose (MC, control), GPD (1,200 mg/kg), or BWD (6,000 mg/kg) was orally administered to rats either as a single dose or multiple doses prior to gefitinib administration. To examine the effects of a single dose of the herbal medicines, gefitinib (10 mg/kg) was orally administered after 5 min or 1 h of MC or the herbal medicine pretreatments. To examine the effects of the multiple doses of the herbal medicines, gefitinib (10 mg/kg) was orally administered following 7 consecutive days of the administration of MC or each herbal medicine. The plasma concentrations of gefitinib were determined with liquid chromatography-tandem mass spectrometry assay. The plasma concentration-time profiles of gefitinib were analyzed with a noncompartmental analysis. RESULTS: Gefitinib was rapidly absorbed and showed a monoexponential decline with an elimination half-life of 3.7-4.1 h. The pharmacokinetics of gefitinib was not affected by GPD pretreatment. However, a significantly lower maximum plasma concentration (Cmax, P<0.05) and area under the curve (P<0.05), and a delayed time to reach Cmax (Tmax, P<0.01) were observed in both single- and multipledose BWD-pretreated rats compared with the control rats. CONCLUSIONS: BWD and not GPD might delay and interfere with gefitinib absorption. Further evaluations of the clinical significance of these findings are needed.

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Weon KY, Kim MG, Shin S, et al. Alterations of Gefitinib Pharmacokinetics by Co-administration of Herbal Medications in Rats. Chin J Integr Med. 2018. PMID: 29335861. doi:10.1007/s11655-017-2907-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。